Pertzye Oral Capsule, Gastro-Resistant Pellets 16000-60500-57500U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Pertzye: Oral capsule, gastro-resistant pellets (16000-60500-57500U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Pertzye 16,000unit DR Capsule
Drug Image file default-drug-image.png
Pertzye 16,000unit DR Capsule

What is this Medicine?

PANCRELIPASE (pan cre LI pase) helps to improve digestion of food by replacing digestive enzymes. This medicine is used to treat health conditions that cause your body to produce less of these enzymes.

CVS Pharmacy Patient Statistics for Pertzye: Oral capsule, gastro-resistant pellets(16000-60500-57500U)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Pertzye (Lipase 16,000unit) Delayed-Release Capsule

NDC: 597670016
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pancreatectomy, Cystic Fibrosis, Pancreatic Insufficiency

Storage Information
Store at room temperature (68 to 77 degrees F); brief excursions permitted to 59 to 104 degrees F
Store in a dry place
Store in original container
Protect from moisture
Pertzye (Lipase 16,000unit) Delayed-Release Capsule

Reported Side Effects for Pertzye (Lipase 16,000unit) Delayed-Release Capsule

Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low Blood Sugar Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Increased Blood Sugar Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
3.0-11.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
3.0-18.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.0-15.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
4.0-10.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Ear Pain Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Pertzye

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5